GATA2 and pachyonychia congenita: Importantly, dilazep exerted anticancer activity against GATA2-dependent (both androgen-dependent and androgen-independent) PC cell lines, while its effect on proliferation of PC-3 and RWPE-1 cells was minimal and only at high concentration.